Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sivan Schipper

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Praxis|June 9, 2016
[Unusual Migraine Manifestations]Sivan Schipper, Andreas R Gantenbein, Peter S Sandor
Expert Review of Neurotherapeutics|February 28, 2012
Acute confusional migraine: our knowledge to dateSivan Schipper, Franz Riederer, Peter S Sándor, et al.
Pain and Therapy|August 20, 2014
Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndromeSivan Schipper, Andreas R Gantenbein, Konrad Maurer, et al.
The Cochrane Database of Systematic Reviews|September 11, 2024
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseasesSivan Schipper, Kabir Nigam, Yasmin Schmid, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Psychedelic-Assisted Therapy in Palliative Care-Insights from an International WorkshopAnna Schuldt, Ian C Clark, Yasmin Schmid, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Praxis|June 9, 2016
[Unusual Migraine Manifestations]Sivan Schipper, Andreas R Gantenbein, Peter S Sandor
Expert Review of Neurotherapeutics|February 28, 2012
Acute confusional migraine: our knowledge to dateSivan Schipper, Franz Riederer, Peter S Sándor, et al.
Pain and Therapy|August 20, 2014
Predictive value of lidocaine for treatment success of oxcarbazepine in patients with neuropathic pain syndromeSivan Schipper, Andreas R Gantenbein, Konrad Maurer, et al.
The Cochrane Database of Systematic Reviews|September 11, 2024
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseasesSivan Schipper, Kabir Nigam, Yasmin Schmid, et al.
Healthcare (Basel, Switzerland)|September 27, 2025
Psychedelic-Assisted Therapy in Palliative Care-Insights from an International WorkshopAnna Schuldt, Ian C Clark, Yasmin Schmid, et al.
Pageof 1